The surgeon general is often described as “America’s doctor,” a figurehead of public health guidance. But what happens when that figure actively questions the very foundations of established medical advice? The recent Senate confirmation hearings for Casey Means, a physician and wellness influencer nominated for the role, revealed a disquieting trend within the Trump administration’s approach to public health: a deliberate erosion of trust in medical institutions coupled with a paradoxical call for increased reliance on individual doctor-patient conversations. This isn’t simply about encouraging informed consent; it’s a strategic shift that redefines the role of public health guidance, and the implications are far-reaching, particularly as we navigate ongoing outbreaks of preventable diseases like measles.
The immediate concern arose during questioning about childhood vaccinations. When asked directly about encouraging parents to vaccinate against measles, Means offered an evasive response, emphasizing her role as “not an individual’s doctor” and advocating for personalized discussions with a physician before any medical intervention. While seemingly deferential to patient autonomy, this stance is particularly jarring given that Means doesn’t currently hold an active medical license. This isn’t an isolated incident. It’s part of a broader pattern initiated by Health Secretary Robert F. Kennedy Jr. and his allies, one that’s actively reshaping federal immunization policy. The core of the issue isn’t empowering patients; it’s creating a climate where established scientific consensus is treated as just another opinion in a marketplace of ideas.
Based on the original theatlantic.com report.
In October 2026, the CDC announced it would no longer recommend universal COVID boosters, instead promoting “shared clinical decision-making.” This approach, as explained by acting CDC director Jim O’Neill, aimed to encourage doctors to discuss both the risks and benefits of vaccination with patients, rather than defaulting to an endorsement. While acknowledging the value of open dialogue, this shift represents a departure from proactive public health messaging. It’s a subtle but significant change: moving from encouraging a protective measure to facilitating a debate about its necessity. This trend escalated in January, when the CDC removed rotavirus, influenza, meningococcal disease, and hepatitis A and B vaccines from the routine childhood immunization schedule, again favoring shared decision-making. Kennedy himself celebrated this as restoring “freedom of choice to American mothers.” However, framing this as simple freedom overlooks the established scientific understanding of these vaccines.
The concept of “shared decision-making” is often presented as a patient-centered approach, but it’s distinct from informed consent. Informed consent is a fundamental ethical principle ensuring patients understand the risks and benefits of a procedure before agreeing to it. Shared decision-making, however, is typically reserved for clinical scenarios with genuine uncertainty – like prostate cancer screening, where the benefits of early detection are modest and the harms of treatment can be significant. Routine immunizations, like the hepatitis-B vaccine, don’t fall into this category. The vaccine is highly effective, the risks are minimal, and the benefits extend to the entire community through herd immunity. To suggest a nuanced discussion about the pros and cons of a vaccine with such a clear risk-benefit profile isn’t adding clarity; it’s introducing doubt where little exists. The CDC’s stated rationale – that shared decision-making is appropriate when “broad vaccination…is unlikely to have population-level impacts” – is a concerning justification for potentially lowering vaccination rates.
This selective application of “epistemic modesty” – a willingness to acknowledge uncertainty – is particularly troubling. While the administration champions patient autonomy in vaccination, it simultaneously issues definitive, and sometimes controversial, pronouncements on other health matters. Kennedy and Trump have offered strong opinions on dietary guidelines and even the use of Tylenol during pregnancy, despite ongoing scientific debate surrounding the latter. This inconsistency suggests that the emphasis on shared decision-making isn’t about genuine respect for patient autonomy, but rather a strategic effort to undermine trust in established medical authorities. Furthermore, many figures within the “Make America Healthy Again” movement have a history of actively discrediting medical professionals, even as they now advocate for patients to consult them. Marty Makary, the FDA Commissioner, has accused doctors of “dogma,” while Vinay Prasad, the FDA’s top vaccine regulator, previously sowed distrust in public health authorities.
The situation demands careful observation. The next steps in research should focus on tracking vaccination rates following these policy changes, specifically monitoring for declines in coverage for diseases like measles, mumps, and rubella. Equally important is research into public perception of vaccines and trust in medical institutions, assessing whether the administration’s messaging is contributing to increased hesitancy. We need to understand not just if vaccination rates are falling, but why. Are parents genuinely seeking more information and engaging in thoughtful discussions with their doctors, or are they simply becoming more skeptical of vaccines due to the amplified rhetoric of doubt? The question isn’t simply about vaccines; it’s about the future of evidence-based public health in an era of deliberate misinformation and eroding trust. Will the administration’s approach lead to a more informed and empowered citizenry, or a resurgence of preventable diseases? The coming months will provide a crucial test.
